Clinical trial
A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in…
NCT00422682 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00422682 |
|---|---|
| Title | A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors |
| Official title | A Phase 1B, Open-Label, Dose Escalation Study Evaluating the Safety of BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | bsi-201 + topotecan, bsi-201 + temozolomide, bsi-201 + gemcitabine, bsi-201 + carboplatin/paclitaxel |
| Enrollment | 136 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Oct 1, 2012 |
| First posted | Jan 17, 2007 |
| Last update posted | Jun 10, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: